270 related articles for article (PubMed ID: 21446773)
1. Lyotropic liquid crystalline self-assembly material behavior and nanoparticulate dispersions of a phytanyl pro-drug analogue of capecitabine-a chemotherapy agent.
Gong X; Moghaddam MJ; Sagnella SM; Conn CE; Danon SJ; Waddington LJ; Drummond CJ
ACS Appl Mater Interfaces; 2011 May; 3(5):1552-61. PubMed ID: 21446773
[TBL] [Abstract][Full Text] [Related]
2. Lamellar crystalline self-assembly behaviour and solid lipid nanoparticles of a palmityl prodrug analogue of Capecitabine--a chemotherapy agent.
Gong X; Moghaddam MJ; Sagnella SM; Conn CE; Danon SJ; Waddington LJ; Drummond CJ
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):349-59. PubMed ID: 21477999
[TBL] [Abstract][Full Text] [Related]
3. Chelating DTPA amphiphiles: ion-tunable self-assembly structures and gadolinium complexes.
Moghaddam MJ; de Campo L; Kirby N; Drummond CJ
Phys Chem Chem Phys; 2012 Oct; 14(37):12854-62. PubMed ID: 22890045
[TBL] [Abstract][Full Text] [Related]
4. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
5. Impurities in commercial phytantriol significantly alter its lyotropic liquid-crystalline phase behavior.
Dong YD; Dong AW; Larson I; Rappolt M; Amenitsch H; Hanley T; Boyd BJ
Langmuir; 2008 Jun; 24(13):6998-7003. PubMed ID: 18522450
[TBL] [Abstract][Full Text] [Related]
6. The influence of dipalmitoyl phosphatidylserine on phase behaviour of and cellular response to lyotropic liquid crystalline dispersions.
Shen HH; Crowston JG; Huber F; Saubern S; McLean KM; Hartley PG
Biomaterials; 2010 Dec; 31(36):9473-81. PubMed ID: 20880581
[TBL] [Abstract][Full Text] [Related]
7. Phase behavior of lipid-based lyotropic liquid crystals in presence of colloidal nanoparticles.
Venugopal E; Bhat SK; Vallooran JJ; Mezzenga R
Langmuir; 2011 Aug; 27(16):9792-800. PubMed ID: 21749073
[TBL] [Abstract][Full Text] [Related]
8. PH-induced nanosegregation of ritonavir to lyotropic liquid crystal of higher solubility than crystalline polymorphs.
Rodríguez-Spong B; Acciacca A; Fleisher D; Rodríguez-Hornedo N
Mol Pharm; 2008; 5(6):956-67. PubMed ID: 19434919
[TBL] [Abstract][Full Text] [Related]
9. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
[TBL] [Abstract][Full Text] [Related]
10. Inverse hexagonal and cubic micellar lyotropic liquid crystalline phase behaviour of novel double chain sugar-based amphiphiles.
Feast GC; Lepitre T; Tran N; Conn CE; Hutt OE; Mulet X; Drummond CJ; Savage GP
Colloids Surf B Biointerfaces; 2017 Mar; 151():34-38. PubMed ID: 27940167
[TBL] [Abstract][Full Text] [Related]
11. Novel steric stabilizers for lyotropic liquid crystalline nanoparticles: PEGylated-phytanyl copolymers.
Chong JY; Mulet X; Keddie DJ; Waddington L; Mudie ST; Boyd BJ; Drummond CJ
Langmuir; 2015 Mar; 31(9):2615-29. PubMed ID: 25068381
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the effect of sugar stereochemistry on biologically relevant lyotropic phases from branched-chain synthetic glycolipids by small-angle X-ray scattering.
Zahid NI; Conn CE; Brooks NJ; Ahmad N; Seddon JM; Hashim R
Langmuir; 2013 Dec; 29(51):15794-804. PubMed ID: 24274824
[TBL] [Abstract][Full Text] [Related]
13. Endogenous nonionic saturated monoethanolamide lipids: solid state, lyotropic liquid crystalline, and solid lipid nanoparticle dispersion behavior.
Sagnella SM; Conn CE; Krodkiewska I; Moghaddam M; Drummond CJ
J Phys Chem B; 2010 Feb; 114(4):1729-37. PubMed ID: 20063872
[TBL] [Abstract][Full Text] [Related]
14. Lanthanide phytanates: liquid-crystalline phase behavior, colloidal particle dispersions, and potential as medical imaging agents.
Conn CE; Panchagnula V; Weerawardena A; Waddington LJ; Kennedy DF; Drummond CJ
Langmuir; 2010 May; 26(9):6240-9. PubMed ID: 20039652
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity evaluation of cytidine-5'-deoxy-5-fluoro-N-[(alkoxy/aryloxy)] carbonyl-cyclic 2',3'-carbonates.
Jhansi Rani V; Raghavendra A; Kishore P; Nanda Kumar Y; Hema Kumar K; Jagadeeswarareddy K
Eur J Med Chem; 2012 Aug; 54():690-6. PubMed ID: 22796042
[TBL] [Abstract][Full Text] [Related]
16. Nonionic diethanolamide amphiphiles with saturated hydrocarbon chains: neat crystalline and lyotropic liquid crystalline phase behavior.
Sagnella SM; Conn CE; Krodkiewska I; Drummond CJ
J Colloid Interface Sci; 2012 Nov; 385(1):87-95. PubMed ID: 22854262
[TBL] [Abstract][Full Text] [Related]
17. A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer.
O'connor T; Rustum Y; Levine E; Creaven P
Cancer Chemother Pharmacol; 2008 Jan; 61(1):125-31. PubMed ID: 17426973
[TBL] [Abstract][Full Text] [Related]
18. Diversifying the solid state and lyotropic phase behavior of nonionic urea-based surfactants.
Fong C; Wells D; Krodkiewska I; Weerawardeena A; Booth J; Hartley PG; Drummond CJ
J Phys Chem B; 2007 Sep; 111(36):10713-22. PubMed ID: 17705418
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine-based combination therapy for breast cancer: implications for nurses.
Frye DK
Oncol Nurs Forum; 2009 Jan; 36(1):105-13. PubMed ID: 19136344
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism and possible biochemical modulation of capecitabine (Xeloda), a newly generated oral fluoropyrimidine].
Saeki T; Takashima S
Gan To Kagaku Ryoho; 1999 Mar; 26(4):447-55. PubMed ID: 10097741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
